Tag:
Samsung
Latest Headlines
Latest Headlines
Samsung says its manufacturing 'DNA' will provide big biosimilar savings
Mention South Korea's prowess in manufacturing and you might think of cheap cars or inexpensive electronics. How about biosimilars?
Samsung plans ambitious rollout of biosims at deep discounts
Samsung BioLogics is moving fast with some ambitious plans to start marketing biosmilars at a deep discount while striking more development deals.
Celltrion boasts worldwide tech lead in biosimilars
South Korea has more biosimilar firepower than just consumer electronics convert Samsung. Celltrion, under the leadership of Seo Jung-jin, is a biosimilars "front-runner," says the CEO. Celltrion has
Samsung, Biogen Idec team on biosimilars
Marching in lockstep with fellow consumer electronics giant Fujifilm toward the prize of biosimilars spoils, Samsung has revealed it will tap Biogen Idec's ( $BIIB ) drug development, manufacturing and
Biogen Idec signs up with Samsung on $300 million biosimilars venture
Biogen Idec CEO George Scangos ( photo ) has made good on his vow to hammer out a major joint venture on biosimilars. The biotech has announced it is joining forces with South Korean conglomerate
Report: Samsung to test genomic analysis service
Count Samsung as an interested player in the growing genomic analysis game. The Seoul-based tech giant's bioinformatics group plans to test a genomic analysis service, which will analyze whole genome
Multinationals eager to jump into the multibillion-dollar biosimilar business
There's a new breed of corporate player jumping into the biotech business. Reuters takes a close look at an unlikely lineup of multinational companies like Samsung , Hanwha Chemical and Fujifilm which
Samsung Medison aiming to become leading devicemaker by 2020
South Korea's Medison and Samsung Electronics have announced a new corporate identity of Samsung Medison, which is aiming to become one of the world's leading medical device companies by 2020,
Fujifilm, Samsung ops notion misguided
Two consumer electronics giants are buying their way into the drug-making business. Perhaps they haven't listened to big pharma explain its massive layoffs over the past few years--or read between
Samsung, Quintiles team on $266M biosimilars deal
Everyone is interested in biosimilars these days--even mobile phone makers. South Korean technology conglomerate Samsung has inked a $266 million deal with CRO Quintiles to produce biosimilar
